WP
PASG icon

Woodline Partners’s Passage Bio PASG Stock Holding History

Woodline Partners’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,201
Closed -$530K – 822
2022
Q3 		$530K Sell
21,201
-68,202
-76% -$2.69M 0.01% 590
2022
Q2 		$4.22M Sell
89,403
-6,291
-7% -$294K 0.07% 287
2022
Q1 		$5.93M Sell
95,694
-57
-0.1% -$4.7K 0.1% 229
2021
Q4 		$12.2M Buy
95,751
+79,661
+495% +$13M 0.17% 160
2021
Q3 		$3.21M Buy
+16,090
New +$3.84M 0.05% 326

Other funds holding PASG

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Woodline Partners's PASG Position: Q4 2022 in Review

Woodline Partners sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 21,201 shares — an estimated $530K sold.

Woodline Partners first reported a position in PASG in Q3 2021 and held it in 5 quarters. The position peaked at $12.2M in Q4 2021. 66 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Woodline Partners reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Woodline Partners sold 21,201 Passage Bio shares in Q4 2022, an estimated $530K.
  • Woodline Partners first reported a position in Passage Bio in Q3 2021 and held it in 5 quarters.
  • Woodline Partners's Passage Bio position peaked at $12.2M in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.